Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of entecavir-treated chronic hepatitis B patients with low-level viremia
ChiCTR2100043266Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tenofovir disoproxil fumarate, tenofovir alafenamide and entecavir in Chronic Hepatitis B (CHB) (4 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: HBV DNA. Started Apr 2021; status: recruiting.
02
Drugs
tenofovir disoproxil fumaratetenofovir alafenamideentecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2100043266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043266.